Daily non-political popular news in brief.
Alzheimer's, Parkinson's, type 2 diabetes similar at molecular level
04-30-2007 · EurekAlert!Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature.
Read more »
Keywords: alzheimer, parkinson, type, diabetes, similar, molecular, level, diabete
« Previous | Next »
Similar news on "Alzheimer's, Parkinson's, type 2 diabetes similar at molecular level":
- Affymetrix 500K array used to identify memory gene
10-19-2006 · EurekAlert!
Affymetrix Inc., announced today that researchers at the Translational Genomics Research Institute in Phoenix, Ariz., have used the Affymetrix 500K Array to discover a gene -- called Kibra -- associated with memory performance in humans. The team's findings may be used to develop new medicines for memory-based diseases such as Alzheimer's and Parkinson's by providing scientists with a better understanding of how memory works at the molecular level.
Similar news · Read more »
- Story ideas from molecular & cellular proteomics
08-22-2007 · EurekAlert!
Story ideas from the Aug. 2007 issue of Molecular & Cellular Proteomics include designing better markers for pregnancy-associated pathological conditions, a potential new therapy for the treatment of Alzheimer's disease and other neurodegenerative conditions, and the first comprehensive study of proteins inside a single type of cell.
Similar news · Read more »
- DNA computing targets West Nile Virus, other deadly diseases
10-16-2006 · EurekAlert!
Researchers say that they have developed a DNA-based computer that could lead to faster, more accurate tests for diagnosing West Nile Virus and bird flu. Representing the first 'medium-scale integrated molecular circuit,' it is the most powerful computing device of its type to date, they say. In the future, the new technology could be used to develop instruments that can simultaneously diagnose and treat cancer, diabetes or other diseases, the scientists suggest.
Similar news · Read more »
- Stanford researchers get precise picture of cell target for drugs
10-25-2007 · EurekAlert!
More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness. Researchers from Stanford University School of Medicine and the Scripps Research Institute have determined what one of those receptors looks like at the molecular level, giving them the keys to greater control of the process.
Similar news · Read more »
- Penn researchers discover new molecular path to fight autoimmune diseases
03-06-2007 · EurekAlert!
Multiple sclerosis, diabetes, and arthritis are among a variety of autoimmune diseases that are aggravated when one type of white blood cell, called the immune regulatory cell, malfunctions. In humans, one cause of this malfunction is when a mutation in a gene called FOXP3 disables the immune cells’ ability to function. Penn researchers have discovered how to modify enzymes that act on the FOXP3 protein, in turn making the regulatory immune cells work better.
Similar news · Read more »
- Penn researchers find potential new target for Type 2 diabetes
06-08-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine have discovered a potential new target for treating type 2 diabetes. The target is a protein, along with its molecular partner, that regulates fat metabolism.
Similar news · Read more »
- Moss protein plays role in Alzheimer's disease
02-08-2008 · EurekAlert!
Preventing Alzheimer's from developing is a goal of Raphael Kopan, Ph.D., professor of molecular biology and pharmacology at the Washington University in St. Louis School of Medicine. The moss plant studied in the laboratory of Ralph S. Quatrano, Ph.D., Spencer T. Olin Professor of biology, might inch Kopan toward that goal. Through collaboration, the researchers have found that a gene in moss is also structurally conserved in AD and has similar functions.
Similar news · Read more »
- Boston College profs study oxidative stress subcellular to discover its role in diseases
09-14-2007 · EurekAlert!
An interdisciplinary team of scientists from Boston College has found a means to discover more about what role oxidative stress plays in the development of diseases by studying it at the subcellular level. Oxidative stress is known to underlie many human diseases including atherosclerosis, Parkinson's disease and Alzheimer's disease.
Similar news · Read more »
- Chronic stress can steal years from caregivers' lifetimes
09-18-2007 · EurekAlert!
The chronic stress that spouses and children develop while caring for Alzheimer's disease patients may shorten the caregivers' lives by as much as four to eight years, a new study suggests. The research also provides concrete evidence that the effects of chronic stress can be seen both at the genetic and molecular level in chronic caregivers' bodies.
Similar news · Read more »
- UIC chemists characterize Alzheimer's neurotoxin structure
12-03-2007 · EurekAlert!
A team of UIC chemists has characterized the molecular structure of the intermediate stage of plaque-forming amyloid fibrils, believed to cause Alzheimer's disease. The finding may lead to new drug targets for this and other amyloid diseases, such as Parkinson's and Creutzfeldt-Jakob.
Similar news · Read more »
